Fresenius Kabi
Dr. Neetu Ojha, PharmD, is a seasoned professional in the pharmaceutical industry, currently serving as a Senior Research Scientist II at Fresenius Kabi since August 2023. Prior to this role, Dr. Ojha held positions as a Senior Research Scientist at Syneos Health from July 2021 to July 2023 and as a Safety and PV Specialist I at Cognizant from October 2019 to June 2021. Dr. Ojha began their career as a Clinical Pharmacist at ESI Hospital in India, working from June 2018 to July 2019, and commenced professional training as a CPA. Dr. Ojha earned a Doctor of Pharmacy degree in Pharmaceutical Sciences from VELS University, completing studies from November 2012 to June 2018, and received foundational education in Biology at Devi Academy Senior Secondary School from 2003 to 2012.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
15 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.